Wuhan Hiteck Biological Pharma Co.,Ltd
SZSE:300683.SZ
46.4 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -128.243 | -7.898 | 30.015 | -25.674 | 61.187 | 91.464 | 141.197 | 156.735 | 83.23 | 108.968 | 77.654 |
| Depreciation & Amortization
| 71.071 | 53.473 | 37.91 | 28.993 | 23.209 | 13.739 | 9.002 | 7.495 | 6.574 | 6.056 | 1.161 |
| Deferred Income Tax
| -25.512 | -3.094 | -14.702 | -23.632 | -7.433 | -7.543 | -4.567 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 12.201 | -7.877 | -56.779 | -64.623 | -13.755 | -50.343 | -89.616 | -20.513 | 8.892 | 21.789 | 0 |
| Accounts Receivables
| 24.423 | 13.489 | -67.497 | -16.408 | 22.511 | 28.256 | -5.333 | -86.234 | 5.88 | -55.331 | 0 |
| Inventory
| -21.904 | -52.45 | -0.751 | -1.805 | -24.895 | -12.058 | -7.458 | 7.237 | 3.05 | -0.097 | 0 |
| Accounts Payables
| 35.194 | 34.178 | 26.171 | -22.778 | -3.939 | -58.998 | -72.258 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 34.106 | -3.094 | -14.702 | -23.632 | -7.433 | -38.285 | -82.158 | -27.75 | 5.843 | 21.886 | 0 |
| Other Non Cash Items
| 50.285 | 15.336 | 0.943 | 41.601 | -7.614 | 18.564 | 22.493 | 0.143 | 61.191 | -1.408 | -1.994 |
| Operating Cash Flow
| 5.314 | 53.034 | 12.088 | -19.703 | 63.028 | 73.423 | 83.077 | 143.86 | 159.887 | 135.405 | 76.821 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -167.441 | -173.972 | -247.113 | -113.629 | -116.154 | -38.67 | -22.255 | -22.051 | -13.623 | -15.645 | -15.714 |
| Acquisitions Net
| 2.069 | -19.721 | -192.719 | -22.144 | -35.496 | -242.085 | 22.264 | 0.002 | 0.015 | 0 | 0 |
| Purchases Of Investments
| -1,809.165 | -1,123.938 | -2,006.719 | -1,017.622 | -1,417.81 | -227.05 | -1,551.3 | -0.968 | -47.5 | 0 | 0 |
| Sales Maturities Of Investments
| 1,482.733 | 1,843.154 | 1,493.72 | 957.221 | 1,912.418 | 69.063 | 780.591 | 6.558 | 12.482 | 12.355 | 0 |
| Other Investing Activites
| -0.126 | -0.167 | -0.179 | 0.036 | 0.001 | 0.002 | 0.009 | 37.002 | -65.985 | -8.483 | 0.54 |
| Investing Cash Flow
| -491.93 | 525.355 | -953.01 | -196.137 | 342.958 | -438.74 | -792.954 | 20.541 | -114.626 | -11.773 | -15.174 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -37.25 | -8.056 | -76.63 | -39 | -7.8 | 0 | 0 | 0 | 0 | 0 | -20 |
| Common Stock Issued
| -0.417 | -0.2 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -2.201 | -1.339 | -0.062 | -16.537 | -20.671 | -31.165 | 0 | -60.867 | -46.337 | 0 | -1.036 |
| Other Financing Activities
| 287.741 | -2.891 | 586.248 | 47.8 | -0.01 | 5.969 | 799.476 | 8 | 25.3 | 173.68 | 1.6 |
| Financing Cash Flow
| 248.291 | -12.287 | 662.816 | -8.183 | -28.486 | -25.196 | 799.476 | -52.867 | -21.037 | 173.68 | -19.436 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.013 | 0.05 | -0.041 | -0.076 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -238.312 | 566.152 | -278.146 | -224.099 | 377.5 | -390.512 | 89.598 | 111.533 | 24.225 | 297.311 | 42.211 |
| Cash At End Of Period
| 510.165 | 748.477 | 182.325 | 460.471 | 684.57 | 307.07 | 697.582 | 607.984 | 496.451 | 472.226 | 174.915 |